RoActemra
- INN
- tocilizumab
- Forms
- Pre-filled syringe;Pre-filled pen;Solution for subcutaneous injection;Concentrate for solution for infusion
- Strengths
- 162 mg (syringe, pen) ;20 mg/ml (concentrate)
- Area
- Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection
- Alternatives
- Yes
What is this? RoActemra is a medicine with the active substance tocilizumab. It is used as an injection or infusion for certain types of arthritis, giant cell arteritis, cytokine release syndrome, and COVID-19.
What's happening? There was a supply issue with RoActemra in the EU. The problem has now been fixed.
Does this affect me? If you were using RoActemra, the shortage is over. You can continue your treatment as normal.
What should I do? Check with your pharmacist or doctor if you have any questions about your medicine.
🤖 Este resumo em linguagem simples é gerado automaticamente a partir do comunicado oficial da agência, com recurso a IA. Destina-se apenas a fins informativos — não constitui aconselhamento médico. Para tomar decisões sobre a sua saúde, consulte sempre um farmacêutico ou médico e leia a fonte oficial vinculada abaixo.
🔬 Detalhes médicos/técnicos (para profissionais)
INN: tocilizumab · Forms: Pre-filled syringe;Pre-filled pen;Solution for subcutaneous injection;Concentrate for solution for infusion · Strengths: 162 mg (syringe, pen) ;20 mg/ml (concentrate) · Area: Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection · Alternatives: Yes
Todas as informações desta página são provenientes do comunicado oficial da agência. Nós as traduzimos e resumimos; não adicionamos nem editamos factos.